Skip to main content

Table 4 Mean values ( x ¯ ±s ) of serum lipid and apolipoprotein levels for the −3826 A > G site of the UCP1 gene in the overweight/obese and control groups

From: Effect of the beta-3 adrenergic receptor Trp64Arg and uncoupling protein 1–3826 A > G genotypes on lipid and apolipoprotein levels in overweight/obese and non-obese Chinese subjects

 

Overweight/Obese

Controls

AA (n = 62)

AG (n = 119)

GG (n = 74)

AA (n = 38)

AG (n = 83)

GG (n = 53)

TG (mmol/L)

1.92 ± 1.21

2.53 ± 1.94a,*

2.23 ± 1.50

1.58 ± 0.83

1.64 ± 1.19

1.88 ± 2.25

TC (mmol/L)

5.28 ± 1.00

5.43 ± 0.86

5.58 ± 0.90

5.39 ± 1.17

5.41 ± 1.03

5.38 ± 1.19

HDL-C (mmol/L)

1.20 ± 0.29

1.17 ± 0.33

1.17 ± 0.31

1.44 ± 0.51

1.43 ± 2.34

1.38 ± 0.41

LDL-C (mmol/L)

d3.16 ± 0.97

e3.24 ± 0.81

f3.44 ± 0.87

g3.20 ± 1.21

h3.21 ± 1.01

i3.19 ± 0.98

apoA-I (mg/dL)

126.06 ± 21.68

125.33 ± 34.42

120.59 ± 18.45

125.77 ± 25.14

130.36 ± 23.34

128.83 ± 24.14

apoA-II (mg/dL)

28.89 ± 4.49

28.38 ± 4.79

27.98 ± 4.35

28.52 ± 4.62

28.87 ± 8.82

29.71 ± 4.12

apoB100 (mg/dL)

100.15 ± 113.51

88.99 ± 17.13

91.14 ± 16.67

88.08 ± 25.74

91.23 ± 88.77

81.35 ± 19.56

ApoC-II (mg/dL)

5.81 ± 2.63

7.22 ± 3.66b,*

6.58 ± 2.91

5.31 ± 2.91

5.61 ± 2.81

5.73 ± 3.59

ApoC-III (mg/dL)

13.99 ± 6.75

16.30 ± 7.25c,*

15.24 ± 6.29

12.53 ± 5.23

13.04 ± 5.60

13.22 ± 7.52

Apo E (mg/dL)

4.93 ± 1.77

5.47 ± 2.07

5.18 ± 1.80

4.55 ± 1.54

4.89 ± 1.89

4.95 ± 3.08

  1. abcCompared with AA genotype carriers in the same group, respectively, *p < 0.05;
  2. Subjects with TG > 4.516 mmol/L (400 mg/dL) were excluded when calculating the serum LDL-C levels, d: n = 43, e: n = 90, f: n = 60, g: n = 34, h: n = 71, i: n = 40.
  3. Age and sex were used as covariates in the analysis to adjust for the genotype effects.